ROYCE & ASSOCIATES LP

Position in TNDM — Tandem Diabetes Care Inc

CIK 906304 New York, NY

Position in TNDM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,589,903

+$236,273 QoQ

Shares Held

900,590

+29.3% QoQ

Ownership

1.29%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#20

of 274 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $200,471,862 across 21 Medical Devices names. TNDM ranks #6 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ESTA	Establishment Labs Holdings Inc.	472,316	$40,529,435
2	BVS	Bioventus Inc.	1,833,212	$17,305,521
3	APYX	Apyx Medical Corp	3,274,064	$14,700,547
4	AORT	Artivion, Inc.	639,282	$14,364,666
5	ENOV	Enovis CORP	662,183	$13,707,188
6	TNDM	Tandem Diabetes Care Inc This page	900,590	$13,589,903
7	UFPT	Ufp Technologies Inc	44,465	$11,789,005
8	CBLL	Ceribell, Inc.	605,010	$11,767,444

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,589,903	900,590	+29.3%	Shares	Sole	2026-08-14
2026-03-31	$13,353,630	696,590	+7.1%	Shares	Sole	2026-05-12
2025-12-31	$14,292,495	650,250	+27.5%	Shares	Sole	2026-02-09
2025-09-30	$6,191,400	510,000	+551.5%	Shares	Sole	2025-11-12
2021-06-30	$7,625,056	78,286	+14.5%	Shares	Sole	2021-08-06
2021-03-31	$6,035,064	68,386	+1.9%	Shares	Sole	2021-05-10
2020-12-31	$6,418,788	67,086	+90.1%	Shares	Sole	2021-02-08
2020-09-30	$4,004,961	35,286	+49.6%	Shares	Sole	2020-11-12
2020-06-30	$2,333,127	23,586	-37.2%	Shares	Sole	2020-08-07
2020-03-31	$2,418,659	37,586	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.